Safety of Oral JAK Inhibitors in Inflammatory Skin Diseases: A Systematic Review and Meta‐Analysis of 43 Real‐World Studies
The authors declare no conflicts of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Yaolong Chen (ORCID: https://orcid.org/0000-0002-7338-4418)
- Hao Guo (ORCID: https://orcid.org/0000-0001-6336-4889)
- Yu Wang (ORCID: https://orcid.org/0000-0001-7288-9150)
- Li Zhang (ORCID: https://orcid.org/0000-0003-2599-952X)
- Dongrui Peng
- Huayu Zhang (ORCID: https://orcid.org/0000-0003-1625-4067)
- Jibin Zhang (ORCID: https://orcid.org/0000-0003-3099-6665)
- Yaxuan Ren
- Yuanyuan Yao (ORCID: https://orcid.org/0000-0002-7513-2919)
- Hui Liu (ORCID: https://orcid.org/0000-0001-8245-6025)
- Wunan Huang (ORCID: https://orcid.org/0009-0003-6781-7701)
- Xinghua Gao (ORCID: https://orcid.org/0009-0004-0130-9859)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Lanzhou University of Technology (CN)
- Gansu University of Traditional Chinese Medicine (CN)
- First Hospital of China Medical University (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
- Lanzhou University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Evidence-Based Medicine
- Published
- 2025-10-04
- DOI
- https://doi.org/10.1111/jebm.70076
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00